Quince Therapeutics Inc

Biotech Stocks Healthcare Stocks

$34.04

+1.63 (+5.03%)

As of Aug 15, 2:36 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 4 31%

Sell 0 0%

Price Target

Analyst Price Target +17.9% upside

Low Target $31.69

Average Target $40.14

High Target $63.06

Current Price $34.04

Current
$34.04

Target
$40.14

$31.69 $40.14 avg $63.06

Scenario Analysis

Bear Case

$31.69

-6.9%

Low target

Base Case

$40.14

+17.9%

Avg target

Bull Case

$63.06

+85.3%

High target

Risk/Reward

12.3x

Highly favorable

Price in Context

52-Week High

$910.00

-96.3% from high

52-Week Low

$15.10

+125.4% from low

Target vs 52W High

$40.14

-95.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%